Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry L A Janssen

Showing results (1-10 of 517) with videos related to

Pageof 52
Sort By:
Gastroenterology & Hepatology|August 9, 2019
Idiopathic Noncirrhotic Portal HypertensionHarry L A Janssen
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 21, 2019
ReplyMayur Brahmania, Harry L A Janssen
The American Journal of Gastroenterology|March 3, 2025
Reply to Wu and ZhangGrishma Hirode, Harry L A Janssen
Current Hepatitis Reports|October 16, 2010
The Role of Interferon in Hepatitis B TherapyVincent Rijckborst, Harry L A Janssen
Gastroenterology|May 22, 2022
ReplyGrishma Hirode, Harry L A Janssen
Gastroenterology|June 1, 2014
Averting hepatocellular carcinoma in chronic hepatitis B with antiviral therapy: tipping the balance or not yet?Harry L A Janssen, Ambreen Arif
Alimentary Pharmacology & Therapeutics|February 13, 2019
Editorial: identifying candidates for pegylated interferon add-on to entecavir therapy in patients with HBeAg-positive chronic hepatitis B - authors' replyKin Seng Liem, Harry L A Janssen
Journal of Hepatology|December 15, 2025
Individualizing endpoints in chronic HBV treatment: HBsAg loss and beyondMilan J Sonneveld, Harry L A Janssen
Current Hepatitis Reports|May 13, 2010
Pros and Cons of Peginterferon Versus Nucleos(t)ide Analogues for Treatment of Chronic Hepatitis BMilan J Sonneveld, Harry L A Janssen
Journal of Hepatology|January 15, 2013
Reply to: "Identification of chronic hepatitis B"Irene K Veldhuijzen, Harry L A Janssen
Pageof 52

Showing results (1-10 of 517) with videos related to

Sort By:
Pageof 52
Gastroenterology & Hepatology|August 9, 2019
Idiopathic Noncirrhotic Portal HypertensionHarry L A Janssen
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 21, 2019
ReplyMayur Brahmania, Harry L A Janssen
The American Journal of Gastroenterology|March 3, 2025
Reply to Wu and ZhangGrishma Hirode, Harry L A Janssen
Current Hepatitis Reports|October 16, 2010
The Role of Interferon in Hepatitis B TherapyVincent Rijckborst, Harry L A Janssen
Gastroenterology|May 22, 2022
ReplyGrishma Hirode, Harry L A Janssen
Gastroenterology|June 1, 2014
Averting hepatocellular carcinoma in chronic hepatitis B with antiviral therapy: tipping the balance or not yet?Harry L A Janssen, Ambreen Arif
Alimentary Pharmacology & Therapeutics|February 13, 2019
Editorial: identifying candidates for pegylated interferon add-on to entecavir therapy in patients with HBeAg-positive chronic hepatitis B - authors' replyKin Seng Liem, Harry L A Janssen
Journal of Hepatology|December 15, 2025
Individualizing endpoints in chronic HBV treatment: HBsAg loss and beyondMilan J Sonneveld, Harry L A Janssen
Current Hepatitis Reports|May 13, 2010
Pros and Cons of Peginterferon Versus Nucleos(t)ide Analogues for Treatment of Chronic Hepatitis BMilan J Sonneveld, Harry L A Janssen
Journal of Hepatology|January 15, 2013
Reply to: "Identification of chronic hepatitis B"Irene K Veldhuijzen, Harry L A Janssen
Pageof 52